Myriad Genetics Inc
NASDAQ: MYGN
$15.49
Closing Price on November 22, 2024
MYGN Articles
These are ten of the top pre-market early analyst upgrades, downgrades, and initiations we have seen from Wall Street early this Tuesday morning: Barrick Gold (ABX) Cut to Sector Perform at CIBC. Big...
Published:
There were many analyst calls this morning, but the problem is that most were on smaller companies or were by second and third tier boutiques. These were the top call from Wall Street this Friday...
Published:
We have provided links through on our day trading alerts page this morning. Each stock is seeing active trading right before the open and brief explanations and analysis are offered at...
Published:
Last Updated:
These are the top pre-market analyst upgrades and downgrades this Wednesday morning in early trading. American Water Works (AWK) Started as Buy at Brean Murray. CardioNet (BEAT) Cut to Hold at...
Published:
How long has it been since a company announced a stock split? More importantly, when was the last from a fairly large company? I can’t recall that off the top of my head either. Mryiad...
Published:
There are actually some stocks which are hitting 52-week highs despite the fact that January was the worst annual start on record and despite the fact that the markets are barely off of fresh lows. ...
Published:
Last Updated:
These are the top pre-market analyst upgrades and positive calls we are seeing from Wall Street firms this Friday morning with more than two hours until the open. Arm Holdings (ARMH) Raised to Buy at...
Published:
Top Pre-Market Analyst Upgrades (AMAG, ANDE, BAC, BMC, CDNS, CTXS, IPAR, JEF, MDR, MYGN, NUVA, SYMC)
These are some of the top pre-market analyst upgrades we are seeing this Wednesday morning: AMAG Pharmaceuticals (AMAG) Started as Overweight at JPMorgan Andersons (ANDE) Started as Outperform at...
Published:
CAM cut to Mkt Perform at Wachovia.CYPB started as Buy at Citigroup.DMAN started as Outperform at Credit Suisse.ENB raised to Outperform at CIBC.ERTS started as Buy at Goldman Sachs.ETFC cut to...
Published:
Myriad Genetics, Inc. (MYGN-NASDAQ) has issued a press release discussing a new study showing that the potential savings to the US healthcare system alone could be $4.0 Trillion from 2010 to 2050. ...
Published:
Last Updated: